ANN ARBOR STAGE III GRADE 2 FOLLICULAR LYMPHOMA
Clinical trials for ANN ARBOR STAGE III GRADE 2 FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE III GRADE 2 FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE III GRADE 2 FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Low-Dose eye radiation shows promise for lymphoma control
Disease control OngoingThis study tests whether a very low dose of radiation (4 Gy) can effectively control indolent B-cell lymphoma or mantle cell lymphoma that has spread to the eye socket. About 50 adults with stage I-IV disease will receive this targeted treatment. The goal is to shrink or stop the…
Matched conditions: ANN ARBOR STAGE III GRADE 2 FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
New triple therapy shows promise for controlling lymphoma without prior treatment
Disease control OngoingThis study tests a combination of three drugs (acalabrutinib, lenalidomide, and rituximab) in 60 people with advanced follicular lymphoma who have not had treatment before. The goal is to see how well the drugs work together to shrink or eliminate cancer. Participants take the dr…
Matched conditions: ANN ARBOR STAGE III GRADE 2 FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 12:01 UTC
-
New Triple-Drug attack shows promise against tough lymphomas
Disease control OngoingThis study tests a new drug combination (ALX148, rituximab, and lenalidomide) in people with slow-growing or fast-growing B-cell non-Hodgkin lymphoma that has not responded to prior treatment. The goal is to find the best dose and see if the combo can shrink or eliminate tumors. …
Matched conditions: ANN ARBOR STAGE III GRADE 2 FOLLICULAR LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New drug cocktail shows promise for lymphoma patients
Disease control OngoingThis early-stage study tested a combination of three drugs (rituximab, lenalidomide, and ibrutinib) in 33 people with untreated follicular lymphoma, a slow-growing blood cancer. The main goal was to find the safest doses and identify side effects. While the drugs aim to control t…
Matched conditions: ANN ARBOR STAGE III GRADE 2 FOLLICULAR LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 19, 2026 11:49 UTC